TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
XOMA

XOMA Royalty Corporation

Healthcare · Biotechnology

40.20$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Ownership

Ownership Structure

Who owns XOMA Royalty Corporation (XOMA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 27.1% of the shares are freely tradable; institutional investors hold 85.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 85.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 27.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 18Mio.

Largest Shareholders

Institutions

Institutions XOMA
Name Stake (%) Shares Change (%) Date
Bvf Inc 14.65 2,590,303 +0.0 03/31/2026
Morgan Stanley - Brokerage Accounts 9.63 1,702,157 -0.7 03/31/2026
FMR Inc 7.37 1,302,974 +12.1 03/31/2026
BlackRock Inc 3.66 646,914 +5.8 03/31/2026
Woodline Partners LP 3.62 640,001 +143.4 03/31/2026
Vanguard Capital Management, LLC 3.11 549,796 +0.0 03/31/2026
Opaleye Management Inc 1.91 338,374 +12.8 06/30/2026

Funds

Funds XOMA
Name Stake (%) Shares Change (%) Date
Fidelity Contrafund 5.34 944,120 +10.5 06/30/2026
Fidelity Contrafund Commingled Pl Cl S 2.06 363,914 +12.4 06/30/2026
Morgan Stanley Insight I 1.43 252,069 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Jul 14, 2026 Bvf Partners L P/Il 10% Owner Other 772,000 – –
Jul 14, 2026 Bvf Partners L P/Il 10% Owner Other 412,000 – –
Jul 14, 2026 Bvf Partners L P/Il 10% Owner Other 2,773,545 – –
Jul 14, 2026 Bvf Partners L P/Il 10% Owner Other 3,635,758 – –
Jul 14, 2026 Montano Maricel Perea Chief Legal Officer Other 65 – –
Jul 14, 2026 Montano Maricel Perea Chief Legal Officer Other 42,306 – –
Jul 14, 2026 Limber Joseph M Director Other 20,000 – –
Jul 14, 2026 Limber Joseph M Director Other 10,000 – –
Jul 14, 2026 Limber Joseph M Director Other 9,532 – –
Jul 14, 2026 Kosacz Barbara Director Other 6,269 – –
Jul 14, 2026 Hughes Owen Chief Executive Officer Other 102,000 – –
Jul 14, 2026 Hughes Owen Chief Executive Officer Other 752 – –
Jul 14, 2026 Hughes Owen Chief Executive Officer Other 191,264 – –
Jul 14, 2026 Wyszomierski Jack L Director Other 21,828 – –
Jul 14, 2026 Hernday Natasha Director Other 4,000 – –
Jul 14, 2026 Hernday Natasha Director Other 9,304 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 2,000 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 82 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 1,500 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 75 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 1,287 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 7,045 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 313 – –
Jul 14, 2026 Sitko Bradley Chief Investment Officer Other 83,765 – –
Jul 14, 2026 Perry Matthew D Director Other 24,138 – –
Jul 14, 2026 Trigilio Jeffrey Chief Financial Officer Other 103,906 – –
Jul 14, 2026 Franklin Heather L Director Other 6,269 – –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?